0
Skip to Content
Home
About Us
PERC Member Institutions
Our Story
Leadership
Contact Us
Joining PERC
News & Updates
News & Updates
Events
Special Interest Groups
DEE-SWAS
EMAtS
Early Life Epilepsy
Epilepsy Behavioral Health
Epilepsy Surgery
Epilepsy Surgery Neuromodulation
Genetics
Health Equity
Infantile Spasms
Lennox-Gastaut Syndrome
Neuropsychology
Psychogenic Nonepileptic Seizures
Sunflower Syndrome
Telehealth
Value-Based
Member Area
Allies in Research
Shop
Donate
Open Menu
Close Menu
Open Menu
Close Menu
Home
About Us
PERC Member Institutions
Our Story
Leadership
Contact Us
Joining PERC
News & Updates
News & Updates
Events
Special Interest Groups
DEE-SWAS
EMAtS
Early Life Epilepsy
Epilepsy Behavioral Health
Epilepsy Surgery
Epilepsy Surgery Neuromodulation
Genetics
Health Equity
Infantile Spasms
Lennox-Gastaut Syndrome
Neuropsychology
Psychogenic Nonepileptic Seizures
Sunflower Syndrome
Telehealth
Value-Based
Member Area
Allies in Research
Shop
Donate
Home
Folder:
About Us
Back
PERC Member Institutions
Our Story
Leadership
Contact Us
Joining PERC
Folder:
News & Updates
Back
News & Updates
Events
Folder:
Special Interest Groups
Back
DEE-SWAS
EMAtS
Early Life Epilepsy
Epilepsy Behavioral Health
Epilepsy Surgery
Epilepsy Surgery Neuromodulation
Genetics
Health Equity
Infantile Spasms
Lennox-Gastaut Syndrome
Neuropsychology
Psychogenic Nonepileptic Seizures
Sunflower Syndrome
Telehealth
Value-Based
Member Area
Allies in Research
Shop
Donate
Age of onset, pharmacoresistance
Genetics
Dec 9
Written By
PERC
AUTHORS
ABSTRACT
LINK
#Abstract
PERC
Previous
Previous
Treatment Practices for Infantile Epileptic Spasms Syndrome: Consensus and Variation in Major U.S. Pediatric Epilepsy Centers
Next
Next
Factors affecting latency to genetic testing in pediatric epilepsies